Dr. Reddy’s to focus on complex products as growth drivers to offset Revlimid revenue loss
Dr. Reddy’s is focusing on a pipeline of complex drugs, including GLP-1 (such as Semaglutide) as well as biosimilars and consumer care to offset the loss of exclusivity for its blockbuster drug ...
The Financial Express58m
TCS CEO Krithivasan responds to 90-hour work week controversy, says ‘we’re making too much of this’, stresses on ‘personal’ balance
TCS Managing Director and CEO K Krithivasan recently weighed in on the ongoing debate about work- life balance, which was ignited by comments from industry figures like L&T Chairman SN Subrahmanyan, ...